Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 25

    JAMA Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data

    JAMA Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data

    supriya kashyap kashyap29 Dec 2016 9:00 AM IST
    Bengaluru : Mylan N.V. and Biocon Ltd. announced that the results of the HERITAGE study have been published in the Journal of the American Medical...
    Glenmark Pharmaceuticals receives ANDA approval for Tretinoin Capsules

    Glenmark Pharmaceuticals receives ANDA approval for Tretinoin Capsules

    supriya kashyap kashyap28 Dec 2016 11:58 AM IST
    Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for...
    Free Distribution of Life Saving and Generic Medicines: Minister Reply

    Free Distribution of Life Saving and Generic Medicines: Minister Reply

    savita thakur thakur27 Dec 2016 11:36 AM IST
    Following is the written reply given by Minister of State (Health and Family Welfare), Sh Faggan Singh Kulaste to Lok Sabha on the issue of Free...
    FDA approves first drug for spinal muscular atrophy

    FDA approves first drug for spinal muscular atrophy

    supriya kashyap kashyap26 Dec 2016 12:08 PM IST
    The U.S. Food and Drug Administration approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular...
    Sale of Medicines through Online Pharmacies: Committee Recommendations

    Sale of Medicines through Online Pharmacies: Committee Recommendations

    savita thakur thakur24 Dec 2016 9:58 AM IST
    The Sub-Committee constituted by the Drugs Consultative Committee (DCC) to examine the issue relating to online sale of drugs has submitted its...
    Med Achievers targets USD 100 million Business from Europe

    Med Achievers targets USD 100 million Business from Europe

    supriya kashyap kashyap24 Dec 2016 9:40 AM IST
    New Delhi : Med Achievers the first of its kind platform in healthcare innovation and global technology incubator in India has facilitated the entry...
    USFDA approves tissue expander breast reconstruction after mastectomy

    USFDA approves tissue expander breast reconstruction after mastectomy

    supriya kashyap kashyap23 Dec 2016 12:38 PM IST
    The U.S. Food and Drug Administration allowed marketing of a new tissue expander system for soft tissue expansion in two-stage breast reconstruction...
    NPPA to embark study on Impact analysis of price regulation of essential drugs

    NPPA to embark study on Impact analysis of price regulation of essential drugs

    supriya kashyap kashyap23 Dec 2016 11:11 AM IST
    Mumbai : The National Pharmaceutical Pricing Authority (NPPA) will soon embark on a research study on 'Impact analysis of price regulation in India...
    FDA approves device to replace fingerstick testing for diabetes treatment

    FDA approves device to replace fingerstick testing for diabetes treatment

    supriya kashyap kashyap22 Dec 2016 12:07 PM IST
    The U.S. Food and Drug Administration expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of...
    Manufacturing an India specific line of medical devices will increase cost to patient, MTaI board

    Manufacturing an India specific line of medical devices will increase cost to patient, MTaI board

    supriya kashyap kashyap22 Dec 2016 11:12 AM IST
    New Delhi : At a board meeting, members of the Medical Technology Association of India (MTaI) discussed the forecast for 2017 for the medical...
    Drugs and Cosmetics Rules, 1945 being amended: AYUSH Minster

    Drugs and Cosmetics Rules, 1945 being amended: AYUSH Minster

    savita thakur thakur20 Dec 2016 11:25 AM IST
    Drugs and Cosmetics Rules, 1945 being amended to prohibit misleading advertisements of Ayurveda, Siddha & Unani Drugs: AYUSH MinsterThis...
    Practo Acquires analytics platform, Enlightiks

    Practo Acquires analytics platform, Enlightiks

    savita thakur thakur17 Dec 2016 12:22 PM IST
    Bangalore: Practo, the leading healthcare platform, announced the acquisition of Enlightiks - a Bangalore based provider of an advanced analytics...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok